Literature DB >> 9294612

Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.

R K Schmidt-Ullrich1, R B Mikkelsen, P Dent, D G Todd, K Valerie, B D Kavanagh, J N Contessa, W K Rorrer, P B Chen.   

Abstract

Accelerated cellular repopulation has been described as a response of tumors to fractionated irradiation in both normal tissue and tumor systems. To identify the mechanisms by which cells enhance their proliferative rate in response to clinically used doses of ionizing radiation (IR) we have studied human mammary and squamous carcinoma cells which are autocrine growth regulated by the epidermal growth factor receptor (EGFR) and its ligands, transforming growth factor-alpha and EGF. Both EGF and IR induced EGFR autophosphorylation, comparable levels of phospholipase C gamma activation as measured by inositol-1,4,5-triphosphate production, and as a consequence oscillations in cytosolic [Ca2+]. Activities of Raf-1 and mitogen-activated protein kinase (MAPK) were also stimulated by EGF and IR by Ca(2+)-dependent mechanisms. All these responses to EGF and IR were dependent upon activation of EGFR as judged by the use of the specific inhibitor of EGFR autophosphorylation, tyrphostin AG1478. Importantly, IR-induced proliferation of A431 cells was also inhibited by AG1478. This is the first report which demonstrates a link between IR-induced activation of proliferative signal transduction pathways and enhanced proliferation. We propose that accelerated repopulation of tumors whose growth is regulated by EGFR is initiated by an IR-induced EGFR activation mechanism that mimics the effects of growth factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294612     DOI: 10.1038/sj.onc.1201275

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  107 in total

1.  Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells.

Authors:  Amit Deorukhkar; Shujun Shentu; Hee Chul Park; Parmeswaran Diagaradjane; Vinay Puduvalli; Bharat Aggarwal; Sushovan Guha; Sunil Krishnan
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

Review 2.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

Review 3.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

4.  Rab5C enhances resistance to ionizing radiation in rectal cancer.

Authors:  Antuani Rafael Baptistella; Michele Christine Landemberger; Marcos Vinicios Salles Dias; Fernanda Salgueiredo Giudice; Bruna Roz Rodrigues; Petrus Paulo Combas Eufrazio da Silva; Edson Kuatelela Cassinela; Tonielli Cristina Lacerda; Fabio Albuquerque Marchi; Adriana Franco Paes Leme; Maria Dirlei Begnami; Samuel Aguiar; Vilma Regina Martins
Journal:  J Mol Med (Berl)       Date:  2019-04-09       Impact factor: 4.599

5.  Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.

Authors:  Jin Cheng; Ling Tian; Jingjing Ma; Yanping Gong; Zhengxiang Zhang; Zhiwei Chen; Bing Xu; Hui Xiong; Chuanyuan Li; Qian Huang
Journal:  Mol Oncol       Date:  2014-08-07       Impact factor: 6.603

Review 6.  HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

Authors:  Kazi M Ahmed; Ning Cao; Jian Jian Li
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

Review 7.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

8.  Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Authors:  Paul D Brown; Sunil Krishnan; Jann N Sarkaria; Wenting Wu; Kurt A Jaeckle; Joon H Uhm; Francois J Geoffroy; Robert Arusell; Gaspar Kitange; Robert B Jenkins; John W Kugler; Roscoe F Morton; Kendrith M Rowland; Paul Mischel; William H Yong; Bernd W Scheithauer; David Schiff; Caterina Giannini; Jan C Buckner
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

Review 9.  Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.

Authors:  Klaus Dittmann; Claus Mayer; H Peter Rodemann
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

10.  [Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].

Authors:  J Dvorak; V Sitorova; A Ryska; I Sirak; I Richter; J Hatlova; A Ferko; B Melichar; J Petera
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.